Abreu Candida, Martins Antonio, Silva Fernando, Canelas Gabriela, Ribeiro Lucia, Pinto Stefano, Sarmento Antonio, Magro Fernando
Department of Infectious Diseases, São João Hospital Center, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Department of Medicine, Faculty of Medicine, University of Porto, Alameda Prof. Hernâni Monteiro, 4200-319 Porto, Portugal.
Vaccines (Basel). 2023 Mar 20;11(3):703. doi: 10.3390/vaccines11030703.
Patients with immune-mediated inflammatory diseases (IMIDs) treated with immunomodulatory therapy present an increased susceptibility to infections. Vaccination is a crucial element in the management of IMID patients; however, rates remain suboptimal. This study intended to clarify the adherence to prescribed vaccines.
This prospective cohort study included 262 consecutive adults with inflammatory bowel disease and rheumatological diseases who underwent an infectious diseases evaluation before initiating or switching immunosuppressive/biological therapy. Vaccine prescription and adherence were assessed during an infectious diseases (ID) consultation using a real-world multidisciplinary clinical project.
At baseline, less than 5% had all their vaccines up-to-date. More than 650 vaccines were prescribed to 250 (95.4%) patients. The most prescribed were pneumococcal and influenza vaccines, followed by hepatitis A and B vaccines. Adherence to each of the vaccines ranged from 69.1-87.3%. Complete adherence to vaccines occurred in 151 (60.4%) patients, while 190 (76%) got at least two-thirds of them. Twenty patients (8%) did not adhere to any of the vaccines. No significant differences were found in the adherence rates of patients with different sociodemographic and health-related determinants.
ID physicians can play a role in the process of increasing vaccine prescription and adherence. However, more data on patients' beliefs and vaccine hesitancy, along with mobilization of all health care professionals and adequate local interventions, shall be considered to improve vaccine adherence.
接受免疫调节治疗的免疫介导性炎症疾病(IMID)患者感染易感性增加。疫苗接种是IMID患者管理的关键要素;然而,接种率仍不理想。本研究旨在阐明对规定疫苗的依从性。
这项前瞻性队列研究纳入了262例连续的患有炎症性肠病和风湿性疾病的成年人,他们在开始或更换免疫抑制/生物治疗前接受了传染病评估。在传染病(ID)咨询期间,使用一个真实世界的多学科临床项目评估疫苗处方和依从性。
在基线时,不到5%的患者所有疫苗均接种最新。为250例(95.4%)患者开了650多种疫苗。开得最多的是肺炎球菌疫苗和流感疫苗,其次是甲型和乙型肝炎疫苗。每种疫苗的依从率在69.1%-87.3%之间。151例(60.4%)患者完全依从疫苗,而190例(76%)患者至少接种了三分之二的疫苗。20例(8%)患者未依从任何疫苗。在不同社会人口统计学和健康相关决定因素的患者中,依从率未发现显著差异。
ID医生在增加疫苗处方和依从性的过程中可以发挥作用。然而,应考虑更多关于患者信念和疫苗犹豫的数据,以及动员所有医疗保健专业人员和进行适当的局部干预,以提高疫苗依从性。